← Leaderboards
Scott G. Franzblau
University Of Illinois At Chicago
$9,832,829
Attributed
$9,832,829
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2006–23$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,832,829 · 4
By mechanism
U19$8,982,549 · 2
R21$850,280 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Ananda Mohan Chakrabarty$1,988,223
- Victoria W Persky$4,745,723
- Pradip Raychaudhuri$16,086,722
- Thomas G Ebrey$1,594,099
- Irina V Dardynskaia$209,593
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadIn VitroMycobacterium TuberculosisTuberculosisProductionDesignStructureIn VivoEvaluationDrug DiscoveryRegimenInsightPharmacologyConsultationsPeptide HydrolasesRibosomesDrug-SensitiveBaseLeadershipMouse ModelAtp PhosphohydrolaseBindingCollaborationsGenetic Transcription
Grant awards (14)
UIC: In vitro In vivo Mtb Pharmacology$963,450
U19 · FY2023 · AI · contact PI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase$445,286
U19 · FY2023 · AI · contact PI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase$850,917
U19 · FY2022 · AI · contact PI
UIC: In vitro In vivo Mtb Pharmacology$850,917
U19 · FY2022 · AI · contact PI
UIC: In vitro In vivo Mtb Pharmacology$1,066,689
U19 · FY2021 · AI · contact PI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase$953,949
U19 · FY2021 · AI · contact PI
UIC: In vitro In vivo Mtb Pharmacology$1,007,216
U19 · FY2020 · AI · contact PI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase$980,256
U19 · FY2020 · AI · contact PI
UIC: In vitro In vivo Mtb Pharmacology$1,012,839
U19 · FY2019 · AI · contact PI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase$851,030
U19 · FY2019 · AI · contact PI
In vitro detection of anti-TB liver metabolites in early drug discovery$234,820
R21 · FY2013 · AI · contact PI
In vitro detection of anti-TB liver metabolites in early drug discovery$194,829
R21 · FY2012 · AI · contact PI
Lead identification of 1,4-benzoxazines as anti-tuberculosis agents$188,131
R21 · FY2007 · AI · contact PI
Lead identification of 1,4-benzoxazines as anti-tuberculosis agents$232,500
R21 · FY2006 · AI · contact PI